Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
42.6M
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
24.7M
-
Shares change
-
+24.7M
-
Total reported value, excl. options
-
$417M
-
Value change
-
+$417M
-
Number of buys
-
42
-
Price
-
$16.92
Significant Holders of Zenas BioPharma, Inc. - Common Stock, par value $0.0001 (ZBIO) as of Q3 2024
43 filings reported holding ZBIO - Zenas BioPharma, Inc. - Common Stock, par value $0.0001 as of Q3 2024.
Zenas BioPharma, Inc. - Common Stock, par value $0.0001 (ZBIO) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.7M shares
of 42.6M outstanding shares and own 58.04% of the company stock.
Largest 10 shareholders include SR One Capital Management, LP (4.91M shares), NEA Management Company, LLC (2.61M shares), FMR LLC (2M shares), Fairmount Funds Management LLC (1.89M shares), NVP Associates, LLC (1.84M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.56M shares), WELLINGTON MANAGEMENT GROUP LLP (1.5M shares), Vivo Capital, LLC (1.18M shares), FEDERATED HERMES, INC. (1.16M shares), and Novo Holdings A/S (1.15M shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.